Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status (Clinical Microbiology and Infection, 2021)

(untitled) - Eyre, DW; Lumley, SF; Wei, J; Cox, S; James, T; Justice, A; Jesuthasan, G; O'Donnell, D; Howarth, A; Hatch, SB; Marsden, BD; Jones, EY; et al.